Carbohydrate-deficient glycoprotein syndrome.

被引:15
作者
de Lonlay, P
Cormier-Daire, V
Vuillaumier-Barrot, S
Cuer, M
Durand, G
Munnich, A
Saudubray, JM
Seta, N
机构
[1] Hop Necker Enfants Malad, Dept Pediat, F-75743 Paris 15, France
[2] Hop Necker Enfants Malad, Dept Genet, F-75743 Paris, France
[3] Hop Bichat, Serv Biochim A, F-75877 Paris 18, France
来源
ARCHIVES DE PEDIATRIE | 2000年 / 7卷 / 02期
关键词
carbohydrate deficient glycoprotein syndrome phosphomannomutase deficiency phosphomannose-isomerase deficiency;
D O I
10.1016/S0929-693X(00)88089-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Carbohydrate-deficient glycoprotein syndrome (CDGS) is a newly delineated group of inherited multisystemic disorders associated with abnormal glycosylation of a number of serum glycoproteins. Several types have been described on the basis of clinical presentation and biochemical changes of the glycosylation of serum transferrin and attributed to different enzymatic defects, their clinical presentations are fully different and a clinical heterogeneity is observed within a same type of CDGS. Patients with CDGS type la usually present with neurologic (hypotonia, strabismus and cerebellar hypoplasia) and cutaneous (inverted nipples, abnormal distribution of adipose tissue) abnormalities, together with multivisceral involvement (digestive, hepatic, cardiac, renal). However, neurologic and cutaneous symptoms may be absent, so that CDGS must be looked for in case of unexplained organ failure such as isolated liver insufficiency; cardiomyopathy: pericarditis, tubulopathy, nephrotic syndrome, vascular accident or retinitis pigmentosa. Patients with CDGS type Ib present with liver disease, enteropathy and hypoglycemia without neurologic involvement. These patients are successfully treated with oral mannose administration, emphasizing the importance of making the diagnosis. Patients with CDGS type Ic present with mild psychomotor retardation and seizures. Patients with CDGS type II have psychomotor retardation associated with severe gastrointestinal disorder dysmorphic features and abnormal electroretinogram. Other types (III, IV) are less clearly defined and the clinical presentation includes convulsive encephalopathy. Biological abnormalities such as mild hepatic cytolysis, hematologic and hormonal abnormalities are consistently observed in CDGS type I, as well as renal hyperechogeneity, leading one to look for this syndrome when they are associated. Until now, only four enzymatic deficiencies have been identified (types la, Ib, Ic, II). (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:173 / 184
页数:12
相关论文
共 66 条
[1]   Carbohydrate-deficient glycoprotein syndrome type 1 with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities [J].
Acarregui, MJ ;
George, TN ;
Rhead, WJ .
JOURNAL OF PEDIATRICS, 1998, 133 (05) :697-700
[2]   Oral ingestion of mannose elevates blood mannose levels: A first step toward a potential therapy for carbohydrate-deficient glycoprotein syndrome type I [J].
Alton, G ;
Kjaergaard, S ;
Etchison, JR ;
Skovby, F ;
Freeze, HH .
BIOCHEMICAL AND MOLECULAR MEDICINE, 1997, 60 (02) :127-133
[3]  
Andreasson S, 1997, AM J OPHTHALMOL, V124, P95
[4]   Lysosomal enzyme activities in serum and leukocytes from patients with carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase deficiency) [J].
Barone, R ;
Carchon, H ;
Jansen, E ;
Pavone, L ;
Fiumara, A ;
Bosshard, NU ;
Gitzelmann, R ;
Jaeken, J .
JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (02) :167-172
[5]   Immunoglobulin levels in patients with carbohydrate-deficient glycoprotein syndrome type I [J].
Bjorklund, JEM ;
Stibler, H ;
Kristiansson, B ;
Johansson, SGO ;
Magnusson, CGM .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1997, 114 (02) :116-119
[6]   Detailed mapping of the phosphomannomutase 2 (PMM2) gene and mutation detection enable improved analysis for Scandinavian CDG type I families [J].
Bjursell, C ;
Wahlström, J ;
Berg, K ;
Stibler, H ;
Kristiansson, B ;
Matthijs, G ;
Martinsson, T .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 (06) :603-611
[7]  
BLENNOW G, 1991, ACTA PAEDIATR SC S, V375, P14
[8]   A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide [J].
Burda, P ;
Borsig, L ;
de Rijk-van Andel, J ;
Wevers, R ;
Jaeken, J ;
Carchon, H ;
Berger, EG ;
Aebi, M .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (04) :647-652
[9]  
Charlwood J, 1998, PRENATAL DIAG, V18, P693
[10]   HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY IN A NEONATE WITH THE CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME [J].
CLAYTON, PT ;
WINCHESTER, BG ;
KEIR, G .
JOURNAL OF INHERITED METABOLIC DISEASE, 1992, 15 (06) :857-861